References
- LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?Expert Opin Drug Deliv200969995100219637982
- OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
- LimSYConstantinescuCSCurrent and future disease-modifying therapies in multiple sclerosisInt J Clin Pract201064563765020456216
- Di BattistaGBertolottoAGasperiniCGhezziAMaimoneDSolaroCMultiple Sclerosis State of the Art (SMART): a qualitative and quantitative analysis of therapy’s adherence, hospital reliability’s perception, and services provided qualityMult Scler Int2014201475231825215236
- SteinbergSCFarisRJChangCFChanATankersleyMAImpact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort studyClin Drug Investig201030289100
- SyedMRogDParkesLShepherdGLPatient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practicePatient Prefer Adherence2014824725524570582
- TanHCaiQAgarwalSStephensonJJKamatSImpact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosisAdv Ther2011281516121153000
- TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol2009256456857619444532
- DevonshireVLapierreYMacdonellRThe Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosisEur J Neurol2011181697720561039
- HansonKAAgashivalaNWyrwichKWRaimundoKKimEBrandesDWTreatment selection and experience in multiple sclerosis: survey of neurologistsPatient Prefer Adherence2014841542224729689
- RinonABuchMHolleyDVerdunEThe MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosisPatient Prefer Adherence2011562964322259240
- LugaresiARottoliMRPattiFFostering adherence to injectable disease-modifying therapies in multiple sclerosisExpert Rev Neurother20141491029104225109614
- CaonCSaundersCSmrtkaJIntroduction: adherence to disease-modifying therapies – key to optimizing outcomes in relapsing multiple sclerosisJ Neurosci Nurs2010425 SupplS1S421049827
- PattiFOptimizing the benefit of multiple sclerosis therapy: the importance of treatment adherencePatient Prefer Adherence201041920165593
- HadjigeorgiouGDardiotisETsivgoulisGObservational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)PLoS One2014911e11393325419842
- PortaccioEAmatoMPImproving compliance with interferon-β therapy in patients with multiple sclerosisCNS Drugs200923645346219480465
- SainiSDSchoenfeldPKaulbackKDubinskyMCEffect of medication dosing frequency on adherence in chronic diseasesAm J Manag Care2009156e22e3319514806
- HaJFLongneckerNDoctor-patient communication: a reviewOchsner J2010101384321603354
- ZolnierekKBDimatteoMRPhysician communication and patient adherence to treatment: a meta-analysisMed Care200947882683419584762
- SmrtkaJCaonCSaundersCBeckerBLBaxterNEnhancing adherence through educationJ Neurosci Nurs2010425 SupplS19S2921049830